NEW YORK (GenomeWeb News) - NanoDetection Technology and three academic research centers plan to develop an onsite avian influenza detection system, the company said today.
The partners are the University of Tennessee Health Science Center, St. Jude Children’s Research Hospital, and Oak Ridge National Laboratory.
The technology is based on a biochip that detects photons produced as a result of DNA hybridization or protein conjugation, which constitutes a “positive” result.
NanoDetection said the detector is “chemistry and sample agnostic,” meaning that the same biochip “can conduct multiple, simultaneous tests and can use most biological and environmental samples.”
NanoDetection Technology CEO Charlie Barnett said the detector’s test results would not require any sophisticated analysis.
Additional details were not disclosed.